FOX 5 spoke exclusively with a participant in a study for a new injectable drug to prevent HIV. Emory University medical ...
A new injectable drug for HIV prevention, lenacapavir, is being hailed as a potential game-changer in the fight against the ...
Lenacapavir, an antiretroviral drug typically used to treat HIV infections, can also effectively prevent them, a phase 3 ...
Health experts say lenacapavir could reduce the number of global HIV infections significantly. But it needs to be cheaper to ...
Nearly all of Latin America was excluded from the deal, sparking concern the world is missing a critical opportunity to stop ...
Lenacapavir, a new twice-yearly injection, offers 96% HIV prevention efficacy, surpassing daily oral PrEP. For oral ...
A recent phase 3 trial found that twice-yearly injections of Lenacapavir reduce the risk of contracting HIV by 96%. | Drug ...
Scientists have developed Lenacapavir, a twice-yearly injection that cuts HIV infection risk by 96% in groundbreaking trials.
Yearly Lenacapavir for HIV Prevention in Men and Gender-Diverse Persons,” published in the November 2024 issue of Infectious ...
While antiviral drugs to treat HIV had been approved a decade earlier, only five out of 33 million people who carried the ...
A deal that allows manufacturers to produce generic versions of lenacapavir has left out some Eastern European countries ...
For oral medications that prevent new HIV infection to be effective, the patient must take certain actions, including ...